Zimmer Biomet Inc. (ZBH)
Zimmer Biomet Statistics
Share Statistics
Zimmer Biomet has 199.06M shares outstanding. The number of shares has increased by -3.24% in one year.
| Shares Outstanding | 199.06M |
| Shares Change (YoY) | -3.24% |
| Shares Change (QoQ) | -0.01% |
| Owned by Institutions (%) | 89.92% |
| Shares Floating | 197.47M |
| Failed to Deliver (FTD) Shares | 1 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 7.2M, so 3.61% of the outstanding shares have been sold short.
| Short Interest | 7.2M |
| Short % of Shares Out | 3.61% |
| Short % of Float | 4.11% |
| Short Ratio (days to cover) | 4.56 |
Valuation Ratios
The PE ratio is 23.74 and the forward PE ratio is 11.06. Zimmer Biomet's PEG ratio is -2.53.
| PE Ratio | 23.74 |
| Forward PE | 11.06 |
| PS Ratio | 2.79 |
| Forward PS | 2 |
| PB Ratio | 1.72 |
| P/FCF Ratio | 18.78 |
| PEG Ratio | -2.53 |
Enterprise Valuation
Zimmer Biomet has an Enterprise Value (EV) of 27.13B.
| EV / Sales | 3.53 |
| EV / EBITDA | 12.05 |
| EV / EBIT | 18.1 |
| EV / FCF | 23.75 |
Financial Position
The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.5.
| Current Ratio | 1.91 |
| Quick Ratio | 0.99 |
| Debt / Equity | 0.5 |
| Debt / EBITDA | 2.76 |
| Debt / FCF | 5.43 |
| Interest Coverage | 5.9 |
Financial Efficiency
Return on Equity is 7.25% and Return on Invested Capital is 5.68%.
| Return on Equity | 7.25% |
| Return on Assets | 4.23% |
| Return on Invested Capital | 5.68% |
| Revenue Per Employee | $451.68K |
| Profits Per Employee | $53.16K |
| Employee Count | 17,000 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 0.98 |
Taxes
| Income Tax | 131.4M |
| Effective Tax Rate | 12.68% |
Stock Price Statistics
The stock price has increased by -19.32% in the last 52 weeks. The beta is 0.84, so Zimmer Biomet's price volatility has been higher than the market average.
| Beta | 0.84 |
| 52-Week Price Change | -19.32% |
| 50-Day Moving Average | 106.1 |
| 200-Day Moving Average | 107.64 |
| Relative Strength Index (RSI) | 25.71 |
| Average Volume (20 Days) | 2.05M |
Income Statement
In the last 12 months, Zimmer Biomet had revenue of 7.68B and earned 903.8M in profits. Earnings per share was 4.45.
| Revenue | 7.68B |
| Gross Profit | 5.49B |
| Operating Income | 1.29B |
| Net Income | 903.8M |
| EBITDA | 2.25B |
| EBIT | 1.25B |
| Earnings Per Share (EPS) | 4.45 |
Balance Sheet
The company has 525.5M in cash and 6.2B in debt, giving a net cash position of -5.68B.
| Cash & Cash Equivalents | 525.5M |
| Total Debt | 6.2B |
| Net Cash | -5.68B |
| Retained Earnings | 11.1B |
| Total Assets | 21.37B |
| Working Capital | 3.08B |
Cash Flow
In the last 12 months, operating cash flow was 1.5B and capital expenditures -356.8M, giving a free cash flow of 1.14B.
| Operating Cash Flow | 1.5B |
| Capital Expenditures | -356.8M |
| Free Cash Flow | 1.14B |
| FCF Per Share | 5.63 |
Margins
Gross margin is 71.46%, with operating and profit margins of 16.74% and 11.77%.
| Gross Margin | 71.46% |
| Operating Margin | 16.74% |
| Pretax Margin | 13.5% |
| Profit Margin | 11.77% |
| EBITDA Margin | 29.31% |
| EBIT Margin | 16.74% |
| FCF Margin | 14.88% |
Dividends & Yields
ZBH pays an annual dividend of $0.96, which amounts to a dividend yield of 0.85%.
| Dividend Per Share | $0.96 |
| Dividend Yield | 0.85% |
| Dividend Growth (YoY) | 0% |
| Payout Ratio | 21.67% |
| Earnings Yield | 4.21% |
| FCF Yield | 5.33% |
Analyst Forecast
The average price target for ZBH is $120, which is 22.6% higher than the current price. The consensus rating is "Hold".
| Price Target | $120 |
| Price Target Difference | 22.6% |
| Analyst Consensus | Hold |
| Analyst Count | 22 |
Stock Splits
The last stock split was on Mar 1, 2022. It was a forward split with a ratio of 103:100.
| Last Split Date | Mar 1, 2022 |
| Split Type | forward |
| Split Ratio | 103:100 |
Scores
| Altman Z-Score | 2.51 |
| Piotroski F-Score | 7 |